This study was designed to compare the efficacy of two artificial tears both containing hyaluronic acid but differing in their osmolarity. A multicentric double-masked, crossover clinical trial was performed in which 158 subjects were randomized to receive either hypotonic or isotonic artificial tears up to 6 times a day. Both treatments were effective in improving signs and symptoms to a similar extent. No adverse events were reported. It was concluded that hypotonic and isotonic eye drops are comparable for the symptomatic treatment of patients suffering from dry eye syndrome.

Keywords:
Dry eye, Sodium hyaluronate, Osmolarity
1.
Gilbard JP, Farris RL, Santamaria J: Osmolarity of tear microvolumes in keratoconjunctivitis sicca. Arch Ophthalmol 1978;96:677–681.
2.
Mishima S, Kubota Z, Farris RL: The tear flow dynamics in normal and keratoconjunctivitis sicca cases. Concilium Ophthalmologicum XXI. Mexico Acta 1970;2:1801–1805.
3.
Gilbard JP: Topical therapy for dry eye. Trans Ophthalmol Soc UK 1985;104:484–488.
4.
Rolando M, Refojo MF, Kenyon K: Increased tear evaporation in eyes with keratoconjunctivitis sicca. Arch Ophthalmol 1983;101:557–558.
5.
Gilbard JP, Carter JB, Sang DN, Refojo MF, Hanninen LA, Kenyon KR: Morphologic effect of hyperosmolarity on rabbit corneal epithelium. Ophthalmology 1984;91:1205–1212.
6.
Gilbard JP, Farris RL: Tear osmolarity and ocular surface disease in keratoconjunctivitis sicca. Arch Ophthalmol 1979;97:1642–1646.
7.
Wright P, Cooper M, Gilvarry AM: Effect of osmolarity of artificial tear drops on relief of dry eye symptoms. BJ6 and beyond. Br J Ophthalmol 1987;71:161–164.
8.
Lemp MA: Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes. CLAO J 1995 Oct;21(4):221–232.
9.
Nelson JD, Farris LR: Sodium hyaluronate and polyvinyl-alcohol artificial tear preparations: A comparison in patients with keratoconjunctivitis sicca. Arch Ophthalmol 1988;106:484–487.
10.
Sand BB, Marner K, Norn MS: Sodium hyaluronate in the treatment of keratoconjunctivitis sicca: A double masked clinical trial. Acta Ophthalmol 1989;67:181–183.
11.
Shimmura S, Ono M, Shinozaki K, Toda I, Takamura E, Mashima Y, Tsubota K: Sodium hyaluronate eyedrops in the treatment of dry eyes. Br J Ophthalmol 1995;79:1007–1011.
12.
Condon PI, McEwen CG, Wright M, Mackintosh G, Prescott RJ, McDonald C: Double blind, randomised, placebo controlled, crossover, multicentre study to determine the efficacy of a 0.1% (w/v) sodium hyaluronate solution (Farmavisc) in the treatment of dry eye. Br J Ophthalmol 1998;83:1121–1124.
13.
Wiegel PH, Frost SJ, McGary CT, LeBouef RD: The role of hyaluronic acid in inflammation and wound healing. Int J Tissue React 1988;10:355–365.
14.
Inoue M, Katakami C: The effect of hyaluronic acid on corneal epithelial cell proliferation. Invest Ophthalmol Vis Sci 1993;34:2313–2315.
15.
Nishida T, Nakamura M, Mishima H, Otori T: Hyaluronan stimulates corneal epithelial migration. Exp Eye Res 1991;53:753–758.
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.